STOCK TITAN

Sharps Technology, Inc. Reminds Shareholders to Vote Before Important Shareholder Meeting on March 28, 2025

Rhea-AI Impact
(No impact)
Rhea-AI Sentiment
(Neutral)
Tags

Sharps Technology (Nasdaq: STSS) has issued a important reminder to shareholders to vote in favor of a proposed reverse stock split at the upcoming shareholder meeting on March 28, 2025. The vote is essential to maintain STSS's Nasdaq listing and prevent delisting to OTC Markets.

The special meeting, scheduled for 10:00 a.m. Eastern Time, requires shareholder approval to meet Nasdaq's minimum bid price requirement of $1.00 per share. Shareholders of record as of January 29, 2025, are eligible to vote. The company's Board of Directors unanimously supports the proposal.

CEO Robert M. Hayes emphasizes that maintaining the Nasdaq listing is vital for ensuring strong liquidity and broad investor access. If approved, the reverse stock split will decrease the number of outstanding shares while increasing the price per share, with shareholders maintaining their same percentage interest in the company.

Shareholders requiring assistance can contact Advantage Proxy at (877) 870-8565 or ksmith@advantageproxy.com. The proxy statement details are available on the SEC website and at virtualshareholdermeeting.com/STSS2025SM.

Sharps Technology (Nasdaq: STSS) ha emesso un importante promemoria agli azionisti per votare a favore di una proposta di frazionamento inverso delle azioni durante l'imminente assemblea degli azionisti il 28 marzo 2025. Il voto è essenziale per mantenere la quotazione di STSS sul Nasdaq e prevenire la delistazione ai mercati OTC.

L'assemblea speciale, programmata per le 10:00 ora orientale, richiede l'approvazione degli azionisti per soddisfare il requisito del prezzo minimo di offerta di $1,00 per azione del Nasdaq. Gli azionisti registrati al 29 gennaio 2025 sono idonei a votare. Il Consiglio di Amministrazione dell'azienda sostiene all'unanimità la proposta.

Il CEO Robert M. Hayes sottolinea che mantenere la quotazione sul Nasdaq è fondamentale per garantire una forte liquidità e un ampio accesso degli investitori. Se approvato, il frazionamento inverso delle azioni ridurrà il numero di azioni in circolazione aumentando al contempo il prezzo per azione, con gli azionisti che manterranno la stessa percentuale di interesse nell'azienda.

Gli azionisti che necessitano di assistenza possono contattare Advantage Proxy al numero (877) 870-8565 o via email a ksmith@advantageproxy.com. I dettagli del documento di delega sono disponibili sul sito web della SEC e su virtualshareholdermeeting.com/STSS2025SM.

Sharps Technology (Nasdaq: STSS) ha emitido un importante recordatorio a los accionistas para votar a favor de una propuesta de división inversa de acciones en la próxima reunión de accionistas el 28 de marzo de 2025. La votación es esencial para mantener la cotización de STSS en Nasdaq y evitar la exclusión a los mercados OTC.

La reunión especial, programada para las 10:00 a.m. hora del Este, requiere la aprobación de los accionistas para cumplir con el requisito de precio mínimo de oferta de $1.00 por acción de Nasdaq. Los accionistas registrados a partir del 29 de enero de 2025 son elegibles para votar. La Junta Directiva de la empresa apoya unánimemente la propuesta.

El CEO Robert M. Hayes enfatiza que mantener la cotización en Nasdaq es vital para garantizar una fuerte liquidez y un amplio acceso para los inversores. Si se aprueba, la división inversa de acciones reducirá el número de acciones en circulación mientras aumenta el precio por acción, manteniendo los accionistas su mismo porcentaje de interés en la empresa.

Los accionistas que necesiten asistencia pueden contactar a Advantage Proxy al (877) 870-8565 o a ksmith@advantageproxy.com. Los detalles de la declaración de poder están disponibles en el sitio web de la SEC y en virtualshareholdermeeting.com/STSS2025SM.

Sharps Technology (Nasdaq: STSS)는 주주들에게 2025년 3월 28일 예정된 주주총회에서 제안된 역주식 분할에 찬성 투표를 하도록 중요한 알림을 발송했습니다. 이 투표는 STSS의 나스닥 상장을 유지하고 OTC 시장에서의 상장 폐지를 방지하는 데 필수적입니다.

동부 표준시 기준 오전 10시에 예정된 특별 회의는 나스닥의 주당 최소 입찰 가격 요구 사항인 $1.00를 충족하기 위해 주주 승인을 필요로 합니다. 2025년 1월 29일 기준으로 주주로 등록된 사람들은 투표할 수 있습니다. 회사의 이사회는 이 제안을 만장일치로 지지합니다.

CEO 로버트 M. 헤이즈는 나스닥 상장을 유지하는 것이 강력한 유동성과 폭넓은 투자자 접근을 보장하는 데 필수적이라고 강조합니다. 만약 승인된다면, 역주식 분할은 유통 주식 수를 줄이는 동시에 주가를 높이며, 주주들은 회사에 대한 동일한 비율의 지분을 유지하게 됩니다.

도움이 필요한 주주들은 Advantage Proxy에 (877) 870-8565로 연락하거나 ksmith@advantageproxy.com으로 이메일을 보낼 수 있습니다. 위임장 세부사항은 SEC 웹사이트와 virtualshareholdermeeting.com/STSS2025SM에서 확인할 수 있습니다.

Sharps Technology (Nasdaq: STSS) a émis un rappel important aux actionnaires pour voter en faveur d'une proposition de division inversée des actions lors de la prochaine assemblée générale des actionnaires le 28 mars 2025. Le vote est essentiel pour maintenir la cotation de STSS sur le Nasdaq et éviter la radiation sur les marchés OTC.

L'assemblée spéciale, prévue à 10h00, heure de l'Est, nécessite l'approbation des actionnaires pour répondre à l'exigence de prix d'offre minimum de 1,00 $ par action du Nasdaq. Les actionnaires enregistrés au 29 janvier 2025 sont éligibles pour voter. Le conseil d'administration de l'entreprise soutient unanimement la proposition.

Le PDG Robert M. Hayes souligne que le maintien de la cotation sur le Nasdaq est vital pour garantir une forte liquidité et un large accès des investisseurs. Si approuvé, la division inversée des actions réduira le nombre d'actions en circulation tout en augmentant le prix par action, les actionnaires conservant leur même pourcentage d'intérêt dans l'entreprise.

Les actionnaires nécessitant de l'aide peuvent contacter Advantage Proxy au (877) 870-8565 ou par e-mail à ksmith@advantageproxy.com. Les détails de la déclaration de procuration sont disponibles sur le site Web de la SEC et sur virtualshareholdermeeting.com/STSS2025SM.

Sharps Technology (Nasdaq: STSS) hat eine wichtige Erinnerung an die Aktionäre herausgegeben, um für einen vorgeschlagenen Reverse-Split der Aktien bei der bevorstehenden Hauptversammlung am 28. März 2025 zu stimmen. Die Abstimmung ist entscheidend, um die Nasdaq-Notierung von STSS aufrechtzuerhalten und eine Delistung an den OTC-Märkten zu verhindern.

Die Sonderversammlung, die für 10:00 Uhr Eastern Time angesetzt ist, benötigt die Genehmigung der Aktionäre, um die Mindestgebotsanforderung von Nasdaq von $1,00 pro Aktie zu erfüllen. Aktionäre, die am 29. Januar 2025 registriert sind, sind wahlberechtigt. Der Vorstand des Unternehmens unterstützt den Vorschlag einstimmig.

CEO Robert M. Hayes betont, dass die Aufrechterhaltung der Nasdaq-Notierung entscheidend für die Gewährleistung einer starken Liquidität und eines breiten Zugangs für Investoren ist. Wenn genehmigt, wird der Reverse-Split die Anzahl der ausstehenden Aktien verringern und gleichzeitig den Preis pro Aktie erhöhen, wobei die Aktionäre ihren gleichen prozentualen Anteil am Unternehmen behalten.

Aktionäre, die Unterstützung benötigen, können Advantage Proxy unter (877) 870-8565 oder ksmith@advantageproxy.com kontaktieren. Die Einzelheiten zur Vollmacht sind auf der SEC-Website und auf virtualshareholdermeeting.com/STSS2025SM verfügbar.

Positive
  • None.
Negative
  • None.

Voting 'FOR' the Proposed Stock Split is Crucial to Keep STSS Listed on Nasdaq and Prevent Delisting to the OTC Markets

NEW YORK, March 20, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (Nasdaq: STSS) (the “Company” or “Sharps”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, is reminding shareholders to vote their proxy in favor of the Company’s proposal before the shareholder meeting, which is scheduled to be held on March 28, 2025, at 10:00 a.m. Eastern Time. Voting 'FOR' the reverse stock split of the Company’s common stock is imperative for Sharps to maintain compliance with Nasdaq’s minimum bid price requirement and ensure that the Company’s common stock remains listed on Nasdaq and is not delisted to the OTC Markets.

If you require any assistance with voting your shares, please contact our proxy solicitation firm at: ADVANTAGE PROXY, INC. | (877) 870-8565 | Email: ksmith@advantageproxy.com.

Robert M. Hayes, Chief Executive Officer, commented on the importance of having a positive shareholder vote: “Please take this important step to protect your investment by voting for the reverse stock split to help ensure that Sharps Technology’s stock remains listed on Nasdaq. Maintaining a Nasdaq listing is crucial for ensuring strong liquidity and providing a broad range of investors the opportunity to trade the stock. If we do not receive the necessary votes, we will be delisted to the OTC Markets, where liquidity could decrease substantially, creating additional challenges for Sharps in meeting its critical goals. We thank the shareholders who have already voted in favor of the reverse stock split proposal and kindly ask those who have not yet voted to please cast their approval today."

Understanding the Importance of a Positive Vote:

  • Without shareholder approval of the reverse stock split proposal at the March 28, 2025, special shareholder meeting, we expect that our stock will be delisted from Nasdaq in the near future. We have requested a hearing with Nasdaq and at that hearing we will present our plan to complete the reverse stock split to achieve the minimum $1.00 Nasdaq stock price requirement. A positive vote outcome will enable Sharps to maintain its Nasdaq listing and prevent delisting to OTC Markets.
  • If our common stock is delisted from Nasdaq, this could adversely affect the value of the securities that you hold and our trading volume, making it more difficult to buy and sell our securities.
  • If shareholders approve the reverse stock split to remain on Nasdaq, the listing should enable Sharps to maintain the current liquidity profile and ease of trading of its common stock, providing a broad range of investors with the ability to trade. Maintaining a Nasdaq listing also helps sustain interest from analysts and brokers covering and trading Sharps' securities.

Sharps Technology thanks its current shareholders for their patience during this process, but it is crucial for shareholders to understand that failing to vote yes on this matter will lead to the risk of delisting from Nasdaq, which would result in the stock trading on the OTC Markets. This would not be in the best interest of shareholders, as it could have a significant consequence on market liquidity and impact the Company’s growth initiatives.

HOW YOU CAN HELP:

The Definitive Proxy Statement on Schedule 14A regarding the special meeting of our shareholders (the “Special Meeting”) states that it is scheduled to be held on Friday, March 28, 2025. Shareholders as of the Special Meeting’s record date, January 29, 2025, are entitled to vote at the Special Meeting and are encouraged to submit their proxy votes beforehand. Sharps’ Board of Directors will unanimously vote in favor of the reverse stock split proposal and urges all shareholders to approve the proposal by voting 'FOR' the reverse stock split. Please vote your shares 'FOR' the proposal today by responding to the proxy materials that were previously sent to all shareholders.

If you require any assistance with voting your shares, please contact our proxy solicitation firm at the telephone number and email below:

ADVANTAGE PROXY, INC.
P.O. Box 10904
Yakima, WA 98909
Toll Free: (877) 870-8565
Collect: (206) 870-8565
Email: ksmith@advantageproxy.com

REVERSE STOCK SPLIT PROCESS:

If the proposal is approved, after the reverse stock split, each shareholder will hold the same percentage interest in the Company as before the reverse stock split; all shareholders will simply hold fewer shares. A reverse stock split decreases the number of our outstanding shares and increases the price per share – and is a mechanism often used by companies to regain and/or maintain compliance with an exchange’s “minimum bid price” listing requirement. For the purpose of regaining compliance with Nasdaq requirements, Nasdaq’s minimum listing price per share is $1.00.

You can read more about the reverse stock split proposal in the Definitive Proxy Statement on Schedule 14A, which was filed with the Securities and Exchange Commission (SEC) on February 11, 2025, and by visiting www.virtualsharehol dermeeting.com/STSS2025SM

A vote 'FOR' the proposal will help protect your investment in Sharps Technology and ensure that you can fully benefit from future potential shareholder value creation by maintaining the Company’s Nasdaq listing. We appreciate your continued interest in Sharps Technology and look forward to sharing more with you as developments occur in future communications.

About Sharps Technology:
Sharps Technology is an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart-safety syringe products to the healthcare industry. The Company’s product lines focus on providing ultra-low waste capabilities, that incorporate syringe technologies that use both passive and active safety features. Sharps also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. The Company has a manufacturing facility in Hungary. For additional information, please visit www.sharpstechnology.com and these recent news stories: SecureGard sales agreementSoloGard sales agreement.

FORWARD-LOOKING STATEMENTS:
This press release contains “forward-looking statements”. Forward-looking statements reflect our current view about future events. When used in this press release, the words “anticipate,” “believe,” “estimate,” “expect,” “future,” “intend,” “plan,” “poised” or the negative of these terms and similar expressions, as they relate to us or our management, identify forward-looking statements. Such statements, include, but are not limited to, statements contained in this press release relating to our business strategy, our future operating results and liquidity, and capital resources outlook. Forward-looking statements are based on our current expectations and assumptions regarding our business, the economy, and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated by the forward-looking statements. They are neither statements of historical fact nor guarantees of assurance of future performance. We caution you therefore against relying on any of these forward-looking statements. Important factors that could cause actual results to differ materially from those in the forward-looking statements include, without limitation, our ability to raise capital to fund continuing operations; our ability to protect our intellectual property rights; the impact of any infringement actions or other litigation brought against us; competition from other providers and products; our ability to develop and commercialize products and services; changes in government regulation; our ability to complete capital raising transactions; and other factors relating to our industry, our operations and results of operations. Actual results may differ significantly from those anticipated, believed, estimated, expected, intended, or planned. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We cannot guarantee future results, levels of activity, performance, or achievements. The Company assumes no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release.

Investor Contact:

Holdsworth Partners
Adam Holdsworth
Phone: 917-497-9287
Email: info@sharpstechnology.com


FAQ

When is the Sharps Technology (STSS) shareholder meeting for the reverse stock split vote?

The shareholder meeting is scheduled for March 28, 2025, at 10:00 a.m. Eastern Time.

What happens if STSS shareholders don't approve the reverse stock split?

Without approval, STSS will likely be delisted from Nasdaq to OTC Markets, potentially resulting in decreased liquidity and trading challenges.

What is the minimum stock price requirement for STSS to maintain Nasdaq listing?

STSS must maintain a minimum bid price of $1.00 per share to comply with Nasdaq listing requirements.

How will the STSS reverse stock split affect shareholders' ownership percentage?

Shareholders will maintain the same percentage interest in the company, but will hold fewer shares at a higher price per share.

What is the record date for voting on the STSS reverse stock split?

Shareholders of record as of January 29, 2025, are eligible to vote on the reverse stock split proposal.
Sharps Tech

NASDAQ:STSS

STSS Rankings

STSS Latest News

STSS Stock Data

263.66k
15.97M
0.59%
10.17%
9.58%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
MELVILLE